Sandoz Group AG

Sandoz Group AG is a global leader in the pharmaceuticals industry, specializing in the development and manufacture of generic drugs and biosimilars. The company, part of the Novartis Group until its spin-off, focuses on providing affordable alternatives to innovative medicines, helping to make healthcare more accessible worldwide. Sandoz's portfolio encompasses a wide array of therapeutic areas, including cardiovascular, central nervous system disorders, oncology, and respiratory diseases. The company's robust pipeline is aimed at addressing unmet medical needs through its commitment to quality, innovation, and sustainability. Sandoz plays a significant role in the global healthcare ecosystem by reducing healthcare costs and increasing the availability of essential medicines. Its strong presence in both developed and emerging markets underscores its importance in promoting global health. Sandoz's dedication to efficiency and effectiveness in pharmaceutical manufacturing has established it as a key player in the generic drug sector, substantially influencing healthcare delivery and access.